Psychotic features, particularly mood incongruence, as a hallmark of severity of bipolar I disorder.

Bipolar I disorder Clinical characteristics Mood congruence Mood incongruence Psychiatric comorbidity Psychotic features Suicide attempts Treatment

Journal

International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983

Informations de publication

Date de publication:
18 Dec 2022
Historique:
received: 20 09 2022
accepted: 24 11 2022
entrez: 18 12 2022
pubmed: 19 12 2022
medline: 19 12 2022
Statut: epublish

Résumé

The occurrence of psychotic features within mood episodes in patients with bipolar I disorder (BD I) has been associated in some studies with a more severe clinical and socio-professional profile. In contrast, other studies establishing the associations of psychotic features in BD I, and in particular of mood-congruent (MC) and mood-incongruent (MI) features, with clinical characteristics have yielded contradictory results. However, many pre-existing studies have been affected by serious methodological limitations. Using a sample of thoroughly assessed patients with BD I our aims were to: (1) establish the proportion of those with MI and MC features, and (2) compare BD I patients with and without psychotic features as well as those with MI to those with MC features on a wide array of socio-demographic and clinical characteristics including course, psychiatric comorbidity and treatment. A sample of 162 treated patients with BD I (60.5% female, mean age = 41.4 (s.d: 10.2) years) was recruited within a large family study of mood disorders. Clinical, course and treatment characteristics relied on information elicited through direct diagnostic interviews, family history reports and medical records. (1) A total of 96 patients (59.3%) had experienced psychotic features over their lifetime. Among them, 44.8% revealed MI features at least once in their lives. (2) Patients with psychotic features were much less likely to be professionally active, revealed alcohol abuse more frequently and used health care, particularly inpatient treatment, more frequently than those without psychotic features. Within patients with psychotic symptoms, those with MI features showed more clinical severity in terms of a higher likelihood of reporting hallucinations, suicidal attempts and comorbid cannabis dependence. Our data provide additional support for both the distinction between BD-I with and without psychotic features as well as the distinction between MI and MC psychotic features. The more severe course of patients with psychotic features, and particularly those with MI psychotic features, highlights the need for thorough psychopathological evaluations to assess the presence of these symptoms to install appropriate treatment.

Sections du résumé

BACKGROUND BACKGROUND
The occurrence of psychotic features within mood episodes in patients with bipolar I disorder (BD I) has been associated in some studies with a more severe clinical and socio-professional profile. In contrast, other studies establishing the associations of psychotic features in BD I, and in particular of mood-congruent (MC) and mood-incongruent (MI) features, with clinical characteristics have yielded contradictory results. However, many pre-existing studies have been affected by serious methodological limitations. Using a sample of thoroughly assessed patients with BD I our aims were to: (1) establish the proportion of those with MI and MC features, and (2) compare BD I patients with and without psychotic features as well as those with MI to those with MC features on a wide array of socio-demographic and clinical characteristics including course, psychiatric comorbidity and treatment.
METHODS METHODS
A sample of 162 treated patients with BD I (60.5% female, mean age = 41.4 (s.d: 10.2) years) was recruited within a large family study of mood disorders. Clinical, course and treatment characteristics relied on information elicited through direct diagnostic interviews, family history reports and medical records.
RESULTS RESULTS
(1) A total of 96 patients (59.3%) had experienced psychotic features over their lifetime. Among them, 44.8% revealed MI features at least once in their lives. (2) Patients with psychotic features were much less likely to be professionally active, revealed alcohol abuse more frequently and used health care, particularly inpatient treatment, more frequently than those without psychotic features. Within patients with psychotic symptoms, those with MI features showed more clinical severity in terms of a higher likelihood of reporting hallucinations, suicidal attempts and comorbid cannabis dependence.
CONCLUSION CONCLUSIONS
Our data provide additional support for both the distinction between BD-I with and without psychotic features as well as the distinction between MI and MC psychotic features. The more severe course of patients with psychotic features, and particularly those with MI psychotic features, highlights the need for thorough psychopathological evaluations to assess the presence of these symptoms to install appropriate treatment.

Identifiants

pubmed: 36528859
doi: 10.1186/s40345-022-00280-6
pii: 10.1186/s40345-022-00280-6
pmc: PMC9760584
doi:

Types de publication

Journal Article

Langues

eng

Pagination

31

Informations de copyright

© 2022. The Author(s).

Références

J Affect Disord. 2001 Mar;63(1-3):215-20
pubmed: 11246098
Am J Psychiatry. 1992 Nov;149(11):1580-4
pubmed: 1415828
Drug Alcohol Depend. 2008 Jan 1;92(1-3):9-19
pubmed: 17643870
Bipolar Disord. 2013 Nov;15(7):774-86
pubmed: 23941660
Compr Psychiatry. 2003 Jul-Aug;44(4):263-9
pubmed: 12923703
Can J Psychiatry. 2013 Apr;58(4):240-8
pubmed: 23547648
Mol Psychiatry. 2014 Mar;19(3):334-41
pubmed: 23459468
Schizophr Res. 2013 Apr;145(1-3):36-42
pubmed: 23403415
Int Psychogeriatr. 2009 Aug;21(4):764-7
pubmed: 19493381
Br J Psychiatry. 2012 Sep;201(3):215-20
pubmed: 22743843
Arch Gen Psychiatry. 1978 Jul;35(7):837-44
pubmed: 678037
Aust N Z J Psychiatry. 2019 Aug;53(8):772-781
pubmed: 30658550
Bipolar Disord. 2013 May;15(3):272-83
pubmed: 23521608
JAMA Psychiatry. 2018 Jan 1;75(1):28-35
pubmed: 29167880
Schizophrenia (Heidelb). 2022 Sep 29;8(1):78
pubmed: 36175509
Bipolar Disord. 2012 Dec;14(8):888-93
pubmed: 23167936
J Affect Disord. 2004 Sep;81(3):279-85
pubmed: 15337333
Front Psychiatry. 2021 May 04;12:656912
pubmed: 34017275
Mol Psychiatry. 2014 Feb;19(2):209-13
pubmed: 24126925
Eur Psychiatry. 2010 Jan;25(1):47-51
pubmed: 19926262
J Affect Disord. 2002 Sep;71(1-3):195-8
pubmed: 12167516
J Affect Disord. 2015 Jan 15;171:120-7
pubmed: 25303028
Hist Psychiatry. 2011 Sep;22(87 Pt 3):315-31
pubmed: 22043664
Compr Psychiatry. 2017 Jul;76:169-176
pubmed: 28531646
Bipolar Disord. 2017 Sep;19(6):417-433
pubmed: 28804990
Transl Psychiatry. 2012 Oct 23;2:e180
pubmed: 23092984
Bipolar Disord. 2007 Nov;9(7):698-705
pubmed: 17988359
Arch Gen Psychiatry. 1977 Oct;34(10):1229-35
pubmed: 911222
Psychol Med. 2019 Sep;49(12):2036-2048
pubmed: 30303059
Arch Gen Psychiatry. 1994 Nov;51(11):849-59; discussion 863-4
pubmed: 7944874
J Affect Disord. 2001 Dec;67(1-3):79-88
pubmed: 11869754
Acta Psychiatr Scand. 2006 Feb;113(2):112-20
pubmed: 16423162
Perm J. 2021 May 12;25:
pubmed: 35348056
Eur Arch Psychiatry Clin Neurosci. 1991;241(3):165-9
pubmed: 1790162
Arch Gen Psychiatry. 1990 Dec;47(12):1106-11
pubmed: 2244795
Schizophr Bull. 2020 Mar 27;:
pubmed: 32219397
J Affect Disord. 2006 Dec;96(3):215-23
pubmed: 16427134
J Affect Disord. 2011 Dec;135(1-3):241-50
pubmed: 21889213
Drug Alcohol Depend. 2002 Jan 1;65(2):149-58
pubmed: 11772476
Psychiatry Res. 2008 Jan 15;157(1-3):211-23
pubmed: 17881063
Asian J Psychiatr. 2022 Jul;73:103118
pubmed: 35468481
J Affect Disord. 2008 Dec;111(2-3):164-9
pubmed: 18378001
Am J Psychiatry. 2002 Jun;159(6):968-74
pubmed: 12042185
Schizophr Bull. 2014 Nov;40(6):1491-8
pubmed: 24282322
Bipolar Disord. 2012 Feb;14(1):19-30
pubmed: 22329469
Arch Gen Psychiatry. 1990 Jul;47(7):658-62
pubmed: 2360859
Am J Psychiatry. 2003 Dec;160(12):2099-107
pubmed: 14638578
Psychol Med. 2022 Mar 24;:1-11
pubmed: 35321777
Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):131-6
pubmed: 19190957
J Affect Disord. 1996 Feb 12;37(1):23-9
pubmed: 8682975
Schizophr Bull. 1992;18(2):273-82
pubmed: 1621073
Arch Gen Psychiatry. 1982 Aug;39(8):879-83
pubmed: 7103676
Psychol Med. 2013 Jun;43(6):1151-60
pubmed: 23034091
Eur Arch Psychiatry Clin Neurosci. 1999;249(4):174-9
pubmed: 10449592
J Affect Disord. 2001 Dec;67(1-3):123-32
pubmed: 11869759
Am J Psychiatry. 2007 Feb;164(2):236-47
pubmed: 17267786
Am J Psychiatry. 2000 Feb;157(2):213-9
pubmed: 10671389
Br J Psychiatry. 2015 Mar;206(3):191-7
pubmed: 25614532
Psychosomatics. 2017 Mar - Apr;58(2):101-112
pubmed: 28139249
JAMA Psychiatry. 2014 Apr;71(4):388-96
pubmed: 24522197
J Nerv Ment Dis. 2007 Mar;195(3):226-32
pubmed: 17468682

Auteurs

Julien Elowe (J)

Department of Psychiatry, Lausanne University Hospital and University of Lausanne, West Sector, Chemin Oscar Forel 3, Prangins, 1197, Canton of Vaud, Switzerland. julien.elowe@chuv.ch.
Department of Psychiatry, Lausanne University Hospital and University of Lausanne, North Sector, Yverdon, Canton of Vaud, Switzerland. julien.elowe@chuv.ch.

Julie Vallat (J)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Enrique Castelao (E)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Marie-Pierre F Strippoli (MF)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Mehdi Gholam (M)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Setareh Ranjbar (S)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Jennifer Glaus (J)

Child and Adolescent Psychiatry Clinics, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.

Kathleen Merikangas (K)

Genetic Epidemiology Research Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.

Benjamin Lavigne (B)

Department of Psychiatry, Lausanne University Hospital and University of Lausanne, West Sector, Chemin Oscar Forel 3, Prangins, 1197, Canton of Vaud, Switzerland.

Pierre Marquet (P)

Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
International Research Unit in Neurodevelopment and Child Psychiatry, Laval University, Quebec, Canada.

Martin Preisig (M)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Caroline L Vandeleur (CL)

Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Classifications MeSH